Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-09-05
1997-12-09
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 514221, 540467, 540480, 540509, A61K 3155, C07D40104, C07D40304, C07D41304
Patent
active
056961103
ABSTRACT:
##STR1## Compounds of formula (I), and salts and prodrugs thereof, wherein X is O,S,NR.sup.4 or CH.sub.2 ; R.sup.1 represents H, certain optionally substituted C.sub.1-6 alkyl, or C.sub.3-7 cycloalkyl; R.sup.2 represents phenyl having certain optional substituents; R.sup.3 represents C.sub.1-6 alkyl, halo or NR.sup.6 R.sup.7 ; m is 2,3 or 4; n is 1,2,3,4,5,6 7 or 8 when X is CH.sub.2 or 2,3,4,5,6,7 or 8 when X is O, S or NR.sup.4 ; and x is 0,1,2, or 3; are CCK and/or gastrin antagonists. They and compositions thereof are therefore useful in therapy.
REFERENCES:
patent: 5302591 (1994-04-01), Fletcher et al.
patent: 5360802 (1994-11-01), Chambers et al.
patent: 5410049 (1995-04-01), Chambers
patent: 5451582 (1995-09-01), Chambers et al.
patent: 5478933 (1995-12-01), Showell
"Biological Properties of the Benzodiazepine Amidine Derivative L-740,093 . . . " by S. Patel et al., Am. Soc. Pharm. Exp. Ther., 46: pp. 943-948, 1994.
"The Effect of Cholecystokinin Receptor Antagonists MK-329 and L-365,260 . . . " by S. Kawabata et al., Regulatory Peptides, vol. 35 (1991), pp. 1-10.
SOCMA Handbook, Amer. Chem. Soc., 1965, p. 554.
M. G. Bock, et al. J. Med. Chem., 1989, 32, 16-23, "Benzodiazepine Gastrin and Brain CCK Receptor Ligands L-365,260".
G. N. Woodruff et al., Neuropeptides, vol. 19, Suppl., pp.45-46 (1991), "Functional Role of Brain CCK Receptors".
A. Hassner et al., Chem. Comm. pp. 590-591 (1967) "A New Synthesis of Amines with Diborane".
Westenberg, et al., New Chemical Drug Eval. Unit, 34th Annual Meeting (31 May 1994), Univ. of Utrecht, Session B "Effects of CCK-B Antagonist L-365,260 on Lactate Induced Panic . . .".
J. M. Gorman et al., Handbook of Anxiety, vol. 3, Neurobiology of Anxiety (1990) "Biological Models of Panic Disorder".
Merck Index, Eighth Edition, p. 941, (1968).
M. F. O'Neill et al., Brain Research, vol. 534, pp. 287-290 (1990) "Blockade of CCK-B receptors by L-365,260 . . . ".
Bourrain Sylvie
Fletcher Stephen Robert
Matassa Victor Giulio
Showell Graham Andrew
Berch Mark L.
Merck Sharp & Dohme Ltd.
North Robert J.
Winokur Melvin
LandOfFree
Benzodiazepine derivatives and their use as antagonists of chole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzodiazepine derivatives and their use as antagonists of chole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzodiazepine derivatives and their use as antagonists of chole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607828